Date: 2011-04-13
Type of information: Capital increase
Company: mondoBIOTECH (Switzerland)
Investors: shareholders
Amount: CHF 8 million (€ 6.2 million)
Funding type: share capital increase
Planned used: mondoBIOTECH intends to use the net proceeds of about CHF 7.35 million to continue to fund its growth strategy and for general corporate purposes. This Swiss biotech company discovers drugs for patients suffering from rare diseases through its internally developed Search&Match methodology. In Search&Match mondoBIOTECH's scientists combine their unique knowledge of biologically active human peptides with advanced technology solutions delivering medicinal product candidates for rare diseases to licensing partners.
Others: mondoBIOTECH holding has raised CHF 8’087’058 million by placing 165’042 new shares, mainly to selected investors. The first trading day of the newly issued shares is planned to be 15 April 2011, and delivery of the newly issued shares is planned to occur on 18 April 2011.
Therapeutic area: Rare diseases
